Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M114,180Revenue $M126,761Net Margin (%)3.4Z-Score4.8
Enterprise Value $M126,031EPS $3.7Operating Margin %6.4F-Score5
P/E(ttm))25.8Cash Flow Per Share $4.1Pre-tax Margin (%)5.6Higher ROA y-yN
Price/Book3.010-y EBITDA Growth Rate %12.6Quick Ratio0.8Cash flow > EarningsY
Price/Sales0.95-y EBITDA Growth Rate %10.6Current Ratio1.4Lower Leverage y-yN
Price/Cash Flow11.4y-y EBITDA Growth Rate %9.2ROA % (ttm)6.4Higher Current Ratio y-yN
Dividend Yield %1.2Insider Buy (3m)0ROE % (ttm)12.0Less Shares Outstanding y-yY
Payout Ratio %27.0Shares Outstanding M1,146ROI % (ttm)8.1Gross Margin Increase y-yN

Gurus Latest Trades with CVS

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
CVSChris Davis 2014-09-30 Reduce-1.52%$76.11 - $82.24
($78.94)
$ 99.626%Reduce -76.1%2,153,905
CVSNWQ Managers 2014-09-30 Reduce-0.14%$76.11 - $82.24
($78.94)
$ 99.626%Reduce -8.48%1,939,169
CVSJoel Greenblatt 2014-09-30 Reduce-0.05%$76.11 - $82.24
($78.94)
$ 99.626%Reduce -85.79%9,348
CVSTom Gayner 2014-06-30 Add0.22%$72.58 - $78.92
($75.58)
$ 99.632%Add 105.21%197,000
CVSJoel Greenblatt 2014-06-30 Add0.05%$72.58 - $78.92
($75.58)
$ 99.632%Add 763.24%65,796
CVSKen Fisher 2014-06-30 Add0.01%$72.58 - $78.92
($75.58)
$ 99.632%Add 76.33%155,365
CVSChris Davis 2014-06-30 Reduce-0.51%$72.58 - $78.92
($75.58)
$ 99.632%Reduce -21.19%9,012,151
CVSNWQ Managers 2014-06-30 Reduce-0.41%$72.58 - $78.92
($75.58)
$ 99.632%Reduce -22.79%2,118,767
CVSScott Black 2014-06-30 Reduce-0.41%$72.58 - $78.92
($75.58)
$ 99.632%Reduce -29.12%126,558
CVSRobert Olstein 2014-03-31 Buy 0.94%$65.44 - $75.3
($70.6)
$ 99.641%New holding, 92000 sh.92,000
CVSPRIMECAP Management 2014-03-31 Add0.23%$65.44 - $75.3
($70.6)
$ 99.641%Add 521.24%3,221,930
CVSTom Gayner 2014-03-31 Buy 0.22%$65.44 - $75.3
($70.6)
$ 99.641%New holding, 96000 sh.96,000
CVSJoel Greenblatt 2014-03-31 Add$65.44 - $75.3
($70.6)
$ 99.641%Add 77.75%7,622
CVSChris Davis 2014-03-31 Reduce-3.79%$65.44 - $75.3
($70.6)
$ 99.641%Reduce -65.41%11,435,259
CVSNWQ Managers 2014-03-31 Reduce-0.14%$65.44 - $75.3
($70.6)
$ 99.641%Reduce -7.26%2,744,031
CVSWallace Weitz 2014-03-31 Sold Out -0.02%$65.44 - $75.3
($70.6)
$ 99.641%Sold Out0
CVSKen Fisher 2014-03-31 Reduce-0.01%$65.44 - $75.3
($70.53)
$ 99.641%Reduce -44.33%88,108
CVSVanguard Health Care Fund 2013-12-31 Add0.23%$56.64 - $71.58
($64.24)
$ 99.655%Add 31.57%4,388,100
CVSJohn Rogers 2013-12-31 Add0.04%$56.64 - $71.58
($64.24)
$ 99.655%Add 76.74%98,420
CVSPRIMECAP Management 2013-12-31 Add0.01%$56.64 - $71.58
($64.24)
$ 99.655%Add 39.63%518,630
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

CVS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
CVS Tom Gayner 2014-09-30218,0000.020.49+10.66%
CVS James Barrow 2014-09-30359,1330.030.04+2.96%
CVS Robert Olstein 2014-09-3092,0000.010.95
CVS Vanguard Health Care Fund 2014-09-304,388,1000.380.89
CVS PRIMECAP Management 2014-09-303,198,4600.280.27-0.24%
CVS Ruane Cunniff 2014-09-3026,55300.01-1.76%
CVS Scott Black 2014-09-30124,3260.011.4-1.76%
CVS Mario Gabelli 2014-09-301,528,0100.130.65-2.28%
CVS John Rogers 2014-09-3095,2750.010.1-3.2%
CVS NWQ Managers 2014-09-301,939,1690.171.7-8.48%
CVS Ken Fisher 2014-09-30140,7540.010.02-9.4%
CVS Chris Davis 2014-09-302,153,9050.190.53-76.1%
CVS Joel Greenblatt 2014-09-309,34800.01-85.79%
Premium Most recent portfolio changes are included for Premium Members only!


CVS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Roberts Jonathan CEVP & President, CVS/caremark 2015-01-07Sell86,487$95.315.98view
MERLO LARRY JPresident and CEO 2015-01-05Sell144,144$94.37.12view
Lofberg Per GHEVP 2015-01-02Sell347,343$95.286.01view
Brennan Troyen AEVP, Chief Medical Officer 2015-01-02Sell50,240$95.715.54view
Sussman AndrewSVP & Pres, CVS/minuteclinic 2015-01-02Sell4,220$95.675.58view
Foulkes HelenaEVP, President-CVS/pharmacy 2014-11-07Sell46,325$88.0614.71view
Bisaccia LisaSVP, Chief HR Officer 2014-10-27Sell33,507$8518.84view
Sussman AndrewSVP & President, MinuteClinic 2014-09-02Sell9,020$79.4527.14view
Joyner J. DavidEVP, Sales & Account Services 2014-08-06Sell123,516$76.132.73view
Boratto Eva CSVP, Cont & Chief Acct Officer 2014-07-21Sell22,107$76.7731.57view

Press Releases about CVS :

    Quarterly/Annual Reports about CVS:

    News about CVS:

    Articles On GuruFocus.com
    Has Gilead Sciences Been Able To Maintain Its Lead Run In The Face Of Competition? Jan 22 2015 
    18 Cool Dividend Growth Large Caps For A Hot Market Jan 14 2015 
    Weekly Insider Sells Highlight: CVS, MNST, CAG, EVHC Jan 11 2015 
    Weekly CEO Sells Highlight: Six Flags Entertainment Corp, Gilead Sciences Inc, Ingersoll-Rand PLC, C Jan 10 2015 
    Oakmark Equity and Income Fund Fourth Quarter 2014 Commentary Jan 09 2015 
    Gilead Strikes Deal with CVS, Hits Back AbbVie Jan 06 2015 
    Why Ballard Power Systems Is a Smart Investment Dec 19 2014 
    McKesson's Growth Is Set to Continue in the Long Run Nov 25 2014 
    CVS Q3 Report Beats Estimates Nov 06 2014 
    Mario Gabelli Comments on CVS Health Corp Oct 29 2014 

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK